In the latest trading session, 8.08 million Core Scientific Inc (NASDAQ:CORZ) shares changed hands as the company’s beta touched 0. With the company’s most recent per share price at $16.68 changing hands around $0.62 or 3.88% at last look, the market valuation stands at $4.66B. CORZ’s current price is a discount, trading about -11.69% off its 52-week high of $18.63. The share price had its 52-week low at $2.61, which suggests the last value was 84.35% up since then. When we look at Core Scientific Inc’s average trading volume, we note the 10-day average is 11.57 million shares, with the 3-month average coming to 10.94 million.
Analysts gave the Core Scientific Inc (CORZ) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.08. If we narrow down to specifics, the data shows that 0 out of 6 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CORZ as a Hold, 6 felt it is a Buy and 0 rated the stock as Underweight. Core Scientific Inc’s EPS for the current quarter is expected to be 0.03.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Core Scientific Inc (NASDAQ:CORZ) trade information
Instantly CORZ is in green as seen in intraday trades today. With action -7.88%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 384.96%, with the 5-day performance at -7.88% in the red. However, in the 30-day time frame, Core Scientific Inc (NASDAQ:CORZ) is 28.03% up. Looking at the short shares, we see there were 33.92 million shares sold at short interest cover period of 3.09 days.
The consensus price target for the stock as assigned by Wall Street analysts is 15.5, meaning bulls need a downside of -7.61% from its recent market value. According to analyst projections, CORZ’s forecast low is 3 with 17 as the target high. To hit the forecast high, the stock’s price needs a -1.92% plunge from its current level, while the stock would need to tank 82.01% for it to hit the projected low.
Core Scientific Inc (CORZ) estimates and forecasts
Data shows that the Core Scientific Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 144.25% over the past 6 months, a -2,711.76% in annual growth rate that is considerably lower than the industry average of 8.00%. Year-over-year growth is forecast to reach 2.05% up from the last financial year.
Consensus estimates given by 11 financial analysts project the company’s revenue in the current quarter to hit an average of 99.58M. 6 analysts are of the opinion that Core Scientific Inc’s revenue for the current quarter will be 106.35M. The company’s revenue for the corresponding quarters a year ago was 141.93M and 179.29M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -29.84%. The estimates for the next quarter sales put growth at -40.68%.
The 2024 estimates are for Core Scientific Inc earnings to decrease by -508.00%.
CORZ Dividends
Core Scientific Inc is expected to release its next quarterly earnings report in January.
Core Scientific Inc (NASDAQ:CORZ)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 10.72% of Core Scientific Inc shares while 67.68% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 75.81%.
Among Mutual Funds, the top two as of Jun 30, 2024 were Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. With 5.97 shares estimated at $99.96 million under it, the former controlled 2.14% of total outstanding shares. On the other hand, iShares Russell 2000 ETF held about 1.71% of the shares, roughly 4.78 shares worth around $79.91 million.
